These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39453422)

  • 21. Characterisation of patients who develop atrial fibrillation-induced cardiomyopathy.
    Ahluwalia N; Honarbakhsh S; Abbass H; Joshi A; Chow AWC; Dhinoja M; Petersen SE; Hunter RJ; Lloyd G; Schilling RJ
    Open Heart; 2024 Nov; 11(2):. PubMed ID: 39608861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum uric acid-lowering effect of sacubitril/valsartan in hypertensive patients: evaluation by switching from angiotensin II receptor blockers.
    Horio T; Iwashima Y; Yoshiyama M; Fukuda D; Hasegawa T; Fujimoto K
    Blood Press Monit; 2024 Dec; 29(6):305-311. PubMed ID: 39345201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial.
    Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM
    Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic Syndrome Nonalcoholic Steatohepatitis Male Mouse With Adeno-Associated Viral Renin as a Novel Model for Heart Failure With Preserved Ejection Fraction.
    Shi Y; Perez-Bonilla P; Chen X; Tam K; Marshall M; Morin J; LaViolette B; Kue NR; Damilano F; Miller RA; Zhang BB; Roth Flach RJ; Hirenallur-Shanthappa D
    J Am Heart Assoc; 2024 Dec; 13(23):e035894. PubMed ID: 39575718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics, treatment and prognosis of patients with chronic heart failure according to ejection fraction. Results of an Ecuadorian registry.
    Moreno-Rondón L; Ortega-Armas ME; Coronel A; Vaca I; Guevara B; Alarcón Cedeño R; Pulla D; Díaz Heredia J; Villavicencio D; Castro-Mejía A
    Acta Cardiol; 2024 Oct; 79(8):942-952. PubMed ID: 39161326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.
    Sobhy M; Eletriby A; Ragy H; Kandil H; Saleh MA; Farag N; Guindy R; Bendary A; Nayel AME; Shawky A; Khairy A; Mortada A; Zarif B; Badran H; Khorshid H; Mahmoud K; Said K; Leon K; Abdelsabour M; Tawfik M; Abdelmegid MAF; Koriem M; Loutfi M; Wadie M; Elnoamany M; Sadaka M; Seleem M; Zahran M; Amin OA; Elkaffas S; Ayad S; Kilany WE; Ammar W; Elawady W; Elhammady W; Abdelhady Y
    Cardiol Ther; 2024 Dec; 13(4):707-736. PubMed ID: 39455534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults.
    Love AMA; Edwards C; Cai RY; Gibbs V
    Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualitative evaluation to understand barriers and facilitators to prescribing angiotensin receptor-neprilysin inhibitors (ARNi) and sodium-glucose cotransporter inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF).
    Pradhan AM; Lussier ME; Nguyen M; Voyce SJ; Wright EA
    J Am Pharm Assoc (2003); 2024; 64(6):102224. PubMed ID: 39209218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults.
    Huang Y; Trollor JN; Foley KR; Arnold SRC
    Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D
    Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical profile of dilated cardiomyopathy in children enrolled in chronic cardiac care: a decade review in a sub-Saharan African tertiary center.
    Gashaw H; Tadele H
    BMC Cardiovasc Disord; 2024 Nov; 24(1):689. PubMed ID: 39614208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrocardiographic and biochemical predictors of left ventricular remodeling early after ST-segment elevation myocardial infarction.
    Doğan M; Canpolat U; Aytemir K
    Future Cardiol; 2024; 20(14):747-754. PubMed ID: 39564790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart Failure and All-Cause Hospitalizations in Patients With Heart Failure: A Meta-Analysis.
    Sayed A; ElRefaei M; Awad K; Salah H; Mandrola J; Foy A
    JAMA Netw Open; 2024 Nov; 7(11):e2446684. PubMed ID: 39602122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical Outcome.
    Pastore MC; Stefanini A; Mandoli GE; Piu P; Diviggiano EE; Iuliano MA; Carli L; Marchese A; Martini L; Pecere A; Cavigli L; Giacomin E; Pagliaro A; Righini FM; Sorini Dini C; Soliman Aboumarie H; Focardi M; D'Ascenzi F; Valente S; Cameli M
    JACC Cardiovasc Imaging; 2024 Dec; 17(12):1399-1408. PubMed ID: 39023499
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.